It’s been more than two years since Eli Lilly announced LillyDirect, a platform that combines telehealth and pharmacy services to provide access to Lilly’s portfolio of diabetes, migraine and obesity medications. The goal is to offer a more transparent and affordable way to access certain drugs. The platform has quickly drawn attention from both consumers and lawmakers.

To understand LillyDirect’s growth and where it’s headed, Senior Writer Anastassia Gliadkovskaya spoke with Jen Mazur, senior vice president and general manager of U.S. LillyDirect and Consumer Services.

To learn more about the topics in this episode: 

• Eli Lilly launches oral GLP-1 drug across US through Lilly Direct, telehealth providers
• Lilly makes website to simplify access to obesity drug Zepbound, plus diabetes and migraine meds
• 'Abuse of power': Senators call out 'shady tactics' after investigating Pfizer, Lilly DTC platforms

 

See omnystudio.com/listener for privacy information.